International
The Morning Science

What science found today

‹
 

Research

RSM01, an extended half-life RSV monoclonal antibody with a high barrier to in vitro resistance

Nature ·

The Brief

  • Nature publishes a research article on RSM01, an RSV monoclonal antibody with an extended half-life.
  • The source reports the antibody has a high barrier to in vitro resistance.
  • The feed entry provides no summary, so further technical details are not available from the sources.

Why it matters

An antibody with a longer half-life could mean less frequent dosing for protecting infants and adults against respiratory syncytial virus, though the sources only confirm the headline claims.

Who’s affected

  • clinicians and researchers working on RSV prevention
  • infectious disease scientists

Timeline

  1. Article listed in Nature subject feed

  2. Medical research : nature.com subject feeds

    RSM01, an extended half-life RSV monoclonal antibody with a high barrier to in vitro resistance

How do you feel about this?

0 Comments

    RSM01, an extended half-life RSV monoclonal antibody with a high barrier to in vitro resistance – The Morning Science